Education
About Us
Working with TipRanks
Follow Us
US Neurosurgical Holdings (USNU)
:USNU
Total Valuation
US Neurosurgical Holdings has a market cap or net worth of $24.19M. The enterprise value is -$651.36K.
Market Cap$24.19M
Enterprise Value-$651.36K
Share Statistics
US Neurosurgical Holdings has 21,409,924 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,409,924
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
US Neurosurgical Holdings’s return on equity (ROE) is -0.49 and return on invested capital (ROIC) is -38.68%.
Return on Equity (ROE)-0.49
Return on Assets (ROA)-0.48
Return on Invested Capital (ROIC)-38.68%
Return on Capital Employed (ROCE)-0.42
Revenue Per Employee0.00
Profits Per Employee-685.00K
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of US Neurosurgical Holdings is -5.99. US Neurosurgical Holdings’s PEG ratio is >-0.01.
PE Ratio-5.99
PS Ratio0.00
PB Ratio0.70
Price to Fair Value2.94
Price to FCF-0.39
Price to Operating Cash Flow-0.61
PEG Ratio>-0.01
Income Statement
In the last 12 months, US Neurosurgical Holdings had revenue of 0.00 and earned -2.06M in profits. Earnings per share was -0.13.
Revenue0.00
Gross Profit0.00
Operating Income-1.79M
Pretax Income-2.22M
Net Income-2.06M
EBITDA-2.21M
Earnings Per Share (EPS)-0.13
Cash Flow
In the last 12 months, operating cash flow was -1.35M and capital expenditures 0.00, giving a free cash flow of -1.35M billion.
Operating Cash Flow-1.35M
Free Cash Flow-1.35M
Free Cash Flow per Share-0.06
Dividends & Yields
US Neurosurgical Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.54
52-Week Price Change59.72%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
US Neurosurgical Holdings upcoming earnings date is May 15, 2018, After Close (Confirmed).
Last Earnings DateInvalid Date
Next Earnings DateMay 15, 2018
Ex-Dividend Date―
Financial Position
US Neurosurgical Holdings as a current ratio of 45.20, with Debt / Equity ratio of 1.86%
Current Ratio45.20
Quick Ratio45.20
Debt to Market Cap<0.01
Net Debt to EBITDA1.80
Interest Coverage Ratio0.00
Taxes
In the past 12 months, US Neurosurgical Holdings has paid -163.00K in taxes.
Income Tax-163.00K
Effective Tax Rate0.07
Enterprise Valuation
US Neurosurgical Holdings EV to EBITDA ratio is -3.78, with an EV/FCF ratio of -5.50.
EV to Sales0.00
EV to EBITDA-3.78
EV to Free Cash Flow-5.50
EV to Operating Cash Flow-5.50
Balance Sheet
US Neurosurgical Holdings has $3.70M in cash and marketable securities with $64.00K in debt, giving a net cash position of -$3.63M billion.
Cash & Marketable Securities$3.70M
Total Debt$64.00K
Net Cash-$3.63M
Net Cash Per Share-$0.17
Tangible Book Value Per Share$0.27
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for US Neurosurgical Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―